FDA Approves Breakthrough Cell Therapy for Metastatic Melanoma
The FDA has approved a groundbreaking cancer therapy that uses a patient's own cells to treat advanced melanoma, marking a significant milestone in cancer treatment. The therapy, developed by Iovance Biotherapeutics, involves extracting tumor-infiltrating lymphocytes from the patient, multiplying them in a lab, and then infusing them back into the body to supercharge the immune system's ability to fight cancer. This approval signals a new era in cancer treatment and offers hope for patients with limited treatment options.
